Promotion of FDA-Regulated Medical Products

This book expands on RAPS’ 2013 publication, FDA Requirements for Prescription Drug Promotion by John Driscoll, to include prescription devices.

Table of Contents

Part I: Fundamentals
Chapter 1 Introduction to the Agencies Involved in Prescription Drug and Device Labeling
Chapter 2 Fundamental Principles for Labeling and Promotion of Prescription Medical Products
Chapter 3 Labeling and Promotion of Regulated Products Prior to Approval and Off-Label Promotion

Part II: Communications to Certain Audiences
Chapter 4 Promotion to Healthcare Professionals and Providers
Chapter 5 Direct Promotion of Prescription Products to Consumers and Patient Populations
Chapter 6 Promotion to Payers and Other Sophisticated Audiences

Part III: Practical Advice for Regulatory Professionals
Chapter 7 Additional Regulatory and Legal Considerations

Appendix 1. Selected Sections of the FD&C Act
Appendix 2. Selected FD&C Act Regulations
Appendix 3. List of Available Guidances Regarding the Labeling, Advertising and Promotion of Prescription Drugs

Joanne S. Hawana, MS, JD, Bethany J. Hills, MPH, JD and Benjamin M. Zegarelli, MS, JD


About the Book

Available formats: print and e-book

This book expands on RAPS’ 2013 publication, FDA Requirements for Prescription Drug Promotion by John Driscoll, to include prescription devices. Its seven chapters are divided into three parts. Part I, Fundamentals, introduces the agencies involved in prescription drug and device labeling, reviews the fundamental prescription drug and device labeling and promotion principles and labeling and promotion of these products prior to approval and for off-label use. Part II, Communications to Certain Audiences, discusses the differences in messaging for healthcare professionals, consumers and more sophisticated audiences. Part III, Practical Advice for Regulatory Professionals, examines additional promotional regulatory and legal considerations.


Who will benefit from this book?

Anyone involved in developing promotional and advertising plans for new prescription medical products would benefit from the information in this book, not just regulatory personnel, but marketing and legal teams as well as management.


Purchasing Options

This book can be purchased in the following formats:

This book can also be purchased as part of the following bundles:


Published by RAPS © 2018. Paperback. 185 pages. ISBN (print): 978-1-947493-25-4. ISBN (digital): 978-1-947493-26-1.

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.